|
exercise |
11 |
|
fgf21 |
10 |
|
mitochondrial dysfunction |
9 |
|
fibroblast growth factor 21 |
7 |
|
obesity |
7 |
|
adipokines |
6 |
|
diabetic cardiomyopathy |
6 |
|
sirt3 |
6 |
|
adiponectin |
5 |
|
cardiac aging |
5 |
|
acetaminophen |
4 |
|
adipose tissue |
4 |
|
atherosclerosis |
4 |
|
cxcl10 |
4 |
|
cxcr3 |
4 |
|
fabp4 |
4 |
|
fgfr1 |
4 |
|
fibroblast growth factors |
4 |
|
hormones |
4 |
|
klb |
4 |
|
metabolic regulation |
4 |
|
pparγ |
4 |
|
tissue-resident memory t cells |
4 |
|
type 1 diabetes |
4 |
|
acute liver injury |
3 |
|
agonistic antibodies |
3 |
|
alternatively activated macrophages |
3 |
|
autophagy |
3 |
|
bodipy |
3 |
|
cardiometabolic disease |
3 |
|
charge reversal |
3 |
|
chemokine |
3 |
|
diabetic kidney disease |
3 |
|
exerkines |
3 |
|
fatty acid metabolism |
3 |
|
ferroptosis |
3 |
|
gut microbiota |
3 |
|
hippo signaling pathway |
3 |
|
il-13 |
3 |
|
il-4 |
3 |
|
immunotherapy |
3 |
|
klotho |
3 |
|
left anterior descending coronary artery ligation |
3 |
|
macrophage |
3 |
|
metabolic complications |
3 |
|
mitochondria |
3 |
|
mortality |
3 |
|
neonatal heart regeneration |
3 |
|
nhanes |
3 |
|
p53 |
3 |
|
pamam |
3 |
|
photodynamic therapy |
3 |
|
pparα |
3 |
|
precision medicine |
3 |
|
prevalence |
3 |
|
protein therapeutics |
3 |
|
rap1 |
3 |
|
th2 immunity |
3 |
|
yes-associated protein 1 |
3 |
|
caloric restriction |
2 |
|
caloric restriction-mimetics |
2 |
|
cardiovascular disease |
2 |
|
cellular localization |
2 |
|
clinical application |
2 |
|
dietary compounds |
2 |
|
fgf |
2 |
|
gender difference |
2 |
|
hypercholesterolemia |
2 |
|
metabolic syndrome |
2 |
|
metabolic syndrome x |
2 |
|
n-glycosylation |
2 |
|
non-alcoholic fatty liver disease |
2 |
|
protein stability |
2 |
|
vascular diseases |
2 |
|
β-klotho |
2 |
|
anxiety- and depression-like behavior |
1 |
|
apoptosis |
1 |
|
aucubin |
1 |
|
biomarker |
1 |
|
cardiovascular system - diseases |
1 |
|
chemokine c-x-c ligand 16 (cxcl16) |
1 |
|
cxcl16 |
1 |
|
cyclophosphamide |
1 |
|
diabetic angiopathies |
1 |
|
diabetic nephropathy |
1 |
|
exercise - physiological aspects |
1 |
|
hippocampus |
1 |
|
immunoclustering |
1 |
|
infiltration factors akt signaling pathway |
1 |
|
inflammatory factors |
1 |
|
liver injury |
1 |
|
machine learning |
1 |
|
mice |
1 |
|
muscle atrophy |
1 |
|
neuroblastoma |
1 |
|
neurogenesis |
1 |
|
neuroinflammation |
1 |
|
neuron apoptosis |
1 |
|
oxidative stress |
1 |
|
sirt1/pgc-1α |
1 |
|
tilapia skin peptides |
1 |
|
tumor microenvironment |
1 |
